Diplomat Pharmacy, Inc. 4
4 · Diplomat Pharmacy, Inc. · Filed Aug 27, 2015
Insider Transaction Report
Form 4
Whelan Sean
DirectorChief Financial Officer
Transactions
- Sale
Common Stock
2015-08-26$37.90/sh−119,852$4,541,947→ 172,212 total - Exercise/Conversion
Common Stock
2015-08-26$4.29/sh+290,064$1,244,375→ 292,064 total - Sale
Common Stock
2015-08-26$38.60/sh−29,682$1,145,734→ 142,530 total - Exercise/Conversion
Employee Option to Acquire Common Stock
2015-08-26−290,064→ 96,686 totalExercise: $4.29Exp: 2022-03-01→ Common Stock (290,064 underlying)
Footnotes (3)
- [F1]The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $37.48 to $38.33 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F2]The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $38.40 to $38.98 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F3]The options were granted on 03/01/2012 and began to vest in annual increments of 25% of the option grant on the one-year anniversary of the date of grant, to be fully vested after four years. The remaining 96,686 options vest on 03/01/2016.